AGO2 and hepatocellular carcinoma: Ago2-mediated RIP assays revealed specific pull-down of both endogenous circPIAS1 and miR-455-3p by anti-Ago2 antibody in HCC cells (Fig. 5D and Supplementary Fig. 2C-D).